UK Markets open in 1 hr 58 mins
  • NIKKEI 225

    26,830.79
    +171.04 (+0.64%)
     
  • HANG SENG

    20,471.54
    -130.98 (-0.64%)
     
  • CRUDE OIL

    113.08
    +0.68 (+0.60%)
     
  • GOLD FUTURES

    1,807.10
    -11.80 (-0.65%)
     
  • DOW

    32,654.59
    +431.17 (+1.34%)
     
  • BTC-GBP

    23,902.61
    -552.22 (-2.26%)
     
  • CMC Crypto 200

    670.17
    +427.49 (+176.16%)
     
  • Nasdaq

    11,984.52
    +321.73 (+2.76%)
     
  • ^FTAS

    4,149.88
    +29.54 (+0.72%)
     

Affluent Medical : Publication of the Universal Registration Document (URD) 2021.

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Affluent Medical
Affluent Medical : Publication of the Universal Registration Document (URD) 2021.

29-Apr-2022 / 17:48 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

PRESS RELEASE

Aix-en-Provence, 29 April 2022 - 17:45

 

 

 

 

 

Publication of the Universal Registration Document

(URD) 2021

 

 

Affluent Medical (ISIN code: FR0013333077 - Ticker: AFME), a French medtech specialising in the international development and industrialisation of innovative medical prostheses, at a clinical stage, to treat urinary incontinence and mitral valve pathology, announces today the availability to the public of its 2021 Universal Registration Document (URD), filed with the Autorité des marchés financiers (AMF) on April 29, 2022, under visa number R. 22-017.

 

This document, which is made available to the public free of charge under the conditions provided for by the regulations in force, can be consulted on the company's website www.affluentmedical.com (Investors corner / Financial documentation), as well as on that of the AMF (www.amf-france.org).

The 2021 Universal Registration Document has been prepared in the European Single Electronic Format (ESEF) in XBRL and includes in particular:

  • the 2021 annual financial report, consisting of the management report, the corporate governance report and the company and consolidated financial statements for the year ended December 31, 2021;

  • the statutory auditors' reports and information on their fees;

  • a description of the share buyback program.

An English version of the 2021 Universal Registration Document will be made available shortly.

 

About Affluent Medical

Affluent Medical is a French player in MedTech, founded by Truffle Capital, with the aim of becoming a global leader in the treatment of heart and vascular diseases, which are the leading cause of death worldwide, and of urinary incontinence, which today affects one in four adults. Affluent Medical develops innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas. The four major technologies developed by the Company are currently in the pre-clinical and clinical study phase. Kalios is set to be the first medical device to be marketed in Europe.

For more information, please visit: www.affluentmedical.com

 

 

Contacts:

AFFLUENT MEDICAL

Jérôme GEOFFROY

Chief Financial and Administrative Officer

investor@affluentmedical.com

ACTIFIN, financial communication

Ghislaine GASPARETTO

+33 (0) 6 21 10 49 24

affluentmedical@actifin.fr

ACTIFIN, financial press relations

Jennifer JULLIA

+33 (0) 6 47 97 54 87

jjullia@actifin.fr

 

PRIMATICE, public relations France
Thomas ROBOREL de CLIMENS
+33 (0) 6 78 12 97 95

thomasdeclimens@primatice.com
 

 

Regulatory filing PDF file

File: Affluent Medical - URD 2021 EN


Language:

English

Company:

Affluent Medical

320 avenue Archimède, Les pléiades III Bâtiment B

13100 Aix en Provence France

France

Phone:

+33 4 42 95 12 20

E-mail:

jerome.geoffroy@affluentmedical.com

Internet:

https://www.affluentmedical.com/

ISIN:

FR0013333077

Euronext Ticker:

AFME

AMF Category:

Annual financial and audit reports / Terms of availability of the annual financial report

EQS News ID:

1340333

 

End of Announcement

EQS News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting